CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 62  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0742
LYS 10.0222
GLU 20.0227
LEU 30.0070
ARG 40.0105
CYS 50.0096
GLN 60.0228
CYS 70.0155
ILE 80.0368
LYS 90.0477
THR 100.0164
TYR 110.0417
SER 120.0742
LYS 130.0697
PRO 140.0203
PHE 150.0129
HIS 160.0223
PRO 170.0139
LYS 180.0223
PHE 190.0154
ILE 200.0223
LYS 210.0245
GLU 220.0227
LEU 230.0241
ARG 240.0197
VAL 250.0157
ILE 260.0056
GLU 270.0189
SER 280.0129
GLY 290.0095
PRO 300.0063
HIS 310.0081
CYS 320.0094
ALA 330.0169
ASN 340.0115
THR 350.0107
GLU 360.0074
ILE 370.0175
ILE 380.0119
VAL 390.0123
LYS 400.0038
LEU 410.0060
SER 420.0202
ASP 430.0245
GLY 440.0098
ARG 450.0331
GLU 460.0164
LEU 470.0216
CYS 480.0114
LEU 490.0107
ASP 500.0237
PRO 510.0126
LYS 520.0423
GLU 530.0198
ASN 540.0199
TRP 550.0114
VAL 560.0179
GLN 570.0199
ARG 580.0203
VAL 590.0098
VAL 600.0089
GLU 610.0128
LYS 620.0165
PHE 630.0096
LEU 640.0176
LYS 650.0460
ARG 660.0357
ALA 670.0342
GLU 680.0340
ASN 690.0632

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.